Search -

Displaying 1 - 19 of 19

Sort: Relevancy | Date

Presentation TCT 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presenter: Michael Reardon

October 30, 2024

Presentation TCT 2024

TCT 928: Comparison of the Self-Expandable Acurate Neo 2 and the New Balloon-Expandable Myval Series Transcatheter Heart Valve at 4-Year Follow-Up

Presenter: Ignacio Amat-Santos

October 28, 2024

Presentation TCT 2023

TCT 261: Review of Short-term Outcomes of ACURATE neo2

Presenter: Akihiro Tobe

October 26, 2023

Presentation TCT 2023

ACURATE Neo2: Update From the ACURATE IDE and Worldwide Studies

Presenter: Pradeep Yadav

October 25, 2023

Presentation TCT 2023

TCT 474: ACURATE neo2 Implantation Without Balloon Predilatation (Direct ACURATE neo2)

Presenter: Ahmed Elkoumy

October 25, 2023

Presentation TCT 2023

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

Presenter: Francesco Giannini

October 25, 2023

Presentation TCT 2022

TCT 605: Single Arterial Access for Transfemoral Transcatheter Aortic Valve Implantation with the Acurate neo Self-expanding Aortic Bioprosthesis

Presenter: Rodrigo Bagur

September 19, 2022

Presentation TCT 2022

TCT 610: BASILICA procedure prior to valve-in-valve TAVR in an ACURATE Neo TAVR prosthesis

Presenter: Anna Damlin

September 18, 2022

Presentation TCT 2022

ACURATE NEO 2

Presenter: Alexandre Cunha Abizaid

September 17, 2022

Presentation TCT 2022

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo vs the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

Presenter: Jonas Lanz

September 17, 2022

Presentation TCT 2019

Mitigating a Devastating Outcome: SENTINEL CPS in TAVR

Presenter: Kendra Grubb

September 27, 2019

Presentation TCT 2019

Real-World Experience of the LOTUS Edge Valve

Presenter: Hemal Gada

September 27, 2019

Presentation TCT 2019

Lessons From the SCOPE I Study and the ACURATE neo Body of Evidence

Presenter: Thomas Pilgrim

September 27, 2019

Presentation TCT 2019

ACURATE neo: Features and Benefits for Optimized TAVR

Presenter: Helge Möllmann

September 27, 2019

Presentation TCT 2019

SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

Presenter: Jonas Lanz

September 27, 2019

Presentation TCT 2019

Program Update: The ACURATE NEO TAVR System

Presenter: Michael Reardon

September 27, 2019

Presentation TCT 2018

Program Update: The ACURATE NEO TAVR System

Presenter: Alexandre Abizaid

September 22, 2018

Presentation TCT 2017

ACURATE Neo Insights From EU Operators (With Case Examples)

Presenter: Ulrich Schäfer

October 31, 2017

Presentation TCT 2017

ACURATE Neo TAVR Technology Review and Clinical Program Updates

Presenter: Thomas Walther

October 31, 2017

Advertisement

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

TCT 928: Comparison of the Self-Expandable Acurate Neo 2 and the New Balloon-Expandable Myval Series Transcatheter Heart Valve at 4-Year Follow-Up

TCT 261: Review of Short-term Outcomes of ACURATE neo2

ACURATE Neo2: Update From the ACURATE IDE and Worldwide Studies

TCT 474: ACURATE neo2 Implantation Without Balloon Predilatation (Direct ACURATE neo2)

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

TCT 605: Single Arterial Access for Transfemoral Transcatheter Aortic Valve Implantation with the Acurate neo Self-expanding Aortic Bioprosthesis

TCT 610: BASILICA procedure prior to valve-in-valve TAVR in an ACURATE Neo TAVR prosthesis

ACURATE NEO 2

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo vs the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

Mitigating a Devastating Outcome: SENTINEL CPS in TAVR

Real-World Experience of the LOTUS Edge Valve

Lessons From the SCOPE I Study and the ACURATE neo Body of Evidence

ACURATE neo: Features and Benefits for Optimized TAVR

SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

Program Update: The ACURATE NEO TAVR System

Program Update: The ACURATE NEO TAVR System

ACURATE Neo Insights From EU Operators (With Case Examples)

ACURATE Neo TAVR Technology Review and Clinical Program Updates

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content